This shows that safranal’s ability to inhibit GBM cells is most likely achieved by inhibiting the PI3K/Akt/mTOR axis, increasing cancer cell apoptosis and regulating the cancer cell cycle. This evidence concerns the gene MTOR and glioblastoma.